Can Facebook Stock Continue To Blow Past Expectations?
Facebook has outgrown its valuations through effective monetization strategies. Barron’s recently generated a buzz after claiming that Facebook stock could rise by a further 20%. What factors will drive Facebook stock higher over the coming months? Flickr Facebook (NSDQ:FB) stock price has risen steadily over the last one year, gaining over 50% in value. In... Read More →
This Low Risk Opportunity Could Propel Qualcomm Inc stock Higher
The Snapdragon Flight kit has powered a fully autonomous Hover Camera drone. Qualcomm’s drone venture is a low-risk, high-reward opportunity. If the chipmaker plays its cards right, it could hit it big by becoming the default choice for drone manufacturers going forward. Flickr Qualcomm, Inc. (NSDQ:QCOM) may be upping the ante for drone makers. The chip-maker... Read More →
This Earnings Catalyst Makes Qualcomm Stock A Buy
Qualcomm’s royalty business is exhibiting patterns of rapid recovery. However, I believe the recent deal with Vivo isn’t completely captured by sell-side models. In other words, there’s a compelling opportunity to buy the stock ahead of a sales/earnings beat. Flickr Qualcomm, Inc. (NSDQ:QCOM) reached a settlement with one of the fastest growing smartphone franchises (Vivo) in... Read More →
Why Promoted Stickers May Not Really Lift Twitter Inc Stock
On the surface Promoted Stickers comes across as a huge revenue opportunity for Twitter. Given the challenges, the financial impact of the move may be less significant. Conservative investors would do well to wait it out, till the impact of live content streaming is visible. Flickr San Francisco, California based microblogging service Twitter (NYSE:TWTR) recently launched... Read More →
Medivation Acquisition Will Be A Positive For Pfizer Stock
US Pharma major Pfizer is about to close a deal to acquire Medivation for $14 billion. Pfizer’s previous deal to acquire Allergen pharma didn’t go through. The impending acquisition will give Pfizer access to Xtandi, a blockbuster prostate cancer treating drug. Flickr US pharma major Pfizer (NYSE:PFE) is all set to acquire prostate-cancer drug maker... Read More →
How Apple Inc. Is Increasing Shareholder Value Through Debt
Apple reported nearly $235B in cash and cash equivalents, as of the latest quarter. However, the company is still raising debt with every passing quarter. The strategy to raise debt could, in itself, create billions of dollars worth of shareholder value. Flickr Apple, Inc. (NSDQ:AAPL) reported a cash balance of $235B in the latest quarter,... Read More →
Can IBM Keep Its Dividend Growing?
Free cash flow levels are still healthy at IBM so dividend growth should continue in the near term. Strategic Imperatives continue to impress. Debt levels must be watched especially with multiple acquisitions on the horizon. Flickr International Business Machines Corp. (NYSE:IBM) is currently trading at $160 a share with an earnings multiple of just over 13.... Read More →
Investors Should Not Buy Twitter Inc Stock On Heightened Speculation
Twitter has regained momentum in recent weeks despite concerns over ad agency spend. This is mostly due to TV licensing and an impending deal with Apple. However, until there’s supportive data on user engagement, investors should remain on the sidelines. Flickr In a recent turn of events, Twitter (NYSE:TWTR) has been able to regain the attention... Read More →
Should You Follow Warren Buffett Into Phillips 66 Stock?
Warren Buffett has bought shares of Phillips 66, a major US based refiner. Some investors may not like this, considering Buffett’s track record in energy investing and Phillips 66’s recent woes. But Phillips 66 could turn out to be a promising pick since it’s much more than just a refiner. Flickr Warren Buffett’s Omaha, Nebraska-based Berkshire Hathaway... Read More →
Is Gilead Sciences Stock A Buy After The Recent Correction?
Gilead is currently suffering from investor apprehension about Harvoni. With a huge pipeline in place, is this kind of stock price hammering justified? What are the strengths that Gilead can depend on, and is this still a good investment? Flickr I think Gilead Sciences, Inc. (NSDQ:GILD) needs to be vindicated after being hammered by investors... Read More →